Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 65


Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 

    Article Cited by others


Helicobacter pylori eradication therapy: A review of current trends

Olokoba A B, Obateru O A, Bojuwoye M O

Year : 2013| Volume: 54| Issue : 1 | Page no: 1-4

   This article has been cited by
1 The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice
Muhammad Abbas,Murad Habib,Muhammad Naveed,Kumaragurubaran Karthik,Kuldeep Dhama,Meiqi Shi,Chen Dingding
Biomedicine & Pharmacotherapy. 2017; 95: 1082
[Pubmed]  [Google Scholar] [DOI]
2 A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients
Blas José Gómez Rodríguez,Luisa Castro Laria,Federico Argüelles Arias,Cristina Castro Márquez,Ángel Caunedo Álvarez,Manuel Romero Gómez
Revista Española de Enfermedades Digestivas. 2017; 109
[Pubmed]  [Google Scholar] [DOI]
3 Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile
Ute Harrison,Muinah A. Fowora,Abiodun T. Seriki,Eva Loell,Susanna Mueller,Margaret Ugo-Ijeh,Charles A. Onyekwere,Olufunmilayo A. Lesi,Jesse A. Otegbayo,Adegboyega Akere,Dennis A. Ndububa,Olusegun Adekanle,Ebere Anomneze,Fatimah B. Abdulkareem,Isaac A. Adeleye,Alexander Crispin,Gabriele Rieder,Wolfgang Fischer,Stella I. Smith,Rainer Haas,Yoshio Yamaoka
PLOS ONE. 2017; 12(5): e0176454
[Pubmed]  [Google Scholar] [DOI]
4 Solution NMR studies onHelicobacter pyloriproteins for antibiotic target discovery
Ki-Young Lee,Bong-Jin Lee
Expert Opinion on Drug Discovery. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection
Andrea Fulgione,Nunzia Nocerino,Marco Iannaccone,Sante Roperto,Federico Capuano,Norberto Roveri,Marco Lelli,Antonio Crasto,Armando Calogero,Argenia Paola Pilloni,Rosanna Capparelli,Hélder A. Santos
PLOS ONE. 2016; 11(7): e0158646
[Pubmed]  [Google Scholar] [DOI]
6 Treatment ofHelicobacter pyloriinfection: Current and future insights
Maliheh Safavi
World Journal of Clinical Cases. 2016; 4(1): 5
[Pubmed]  [Google Scholar] [DOI]
7 Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori
Yuping Yuan,Qinyi Wu,Guoxiang Cheng,Xuefang Liu,Siguo Liu,Juan Luo,Aimin Zhang,Li Bian,Jianquan Chen,Jiajun Lv,Xiangqian Dong,Gang Yang,Yunzhen Zhu,Lanqing Ma
International Journal of Molecular Medicine. 2015;
[Pubmed]  [Google Scholar] [DOI]
8 Probiotics inHelicobacter pylorieradication therapy: A systematic review and meta-analysis
Min-Min Zhang
World Journal of Gastroenterology. 2015; 21(14): 4345
[Pubmed]  [Google Scholar] [DOI]
9 Predictive Computational Modeling of the Mucosal Immune Responses during Helicobacter pylori Infection
Adria Carbo,Josep Bassaganya-Riera,Mireia Pedragosa,Monica Viladomiu,Madhav Marathe,Stephen Eubank,Katherine Wendelsdorf,Keith Bisset,Stefan Hoops,Xinwei Deng,Maksudul Alam,Barbara Kronsteiner,Yongguo Mei,Raquel Hontecillas,Hiroyoshi Nishikawa
PLoS ONE. 2013; 8(9): e73365
[Pubmed]  [Google Scholar] [DOI]


Read this article